Status:
UNKNOWN
Correlation Between Platelet Function Analyzer-100 Testing and Bleeding Events After Percutaneous Kidney Biopsy
Lead Sponsor:
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Collaborating Sponsors:
Prof. Carlo Manno
Dott. Francesco Pesce
Conditions:
Blood Platelet Disorder
Hemorrhage
Eligibility:
All Genders
18-85 years
Brief Summary
Kidney biopsy represents the criterion standard to obtain information on diagnosis and prognosis of renal dysfunctions . Many patients with kidney disease have a predisposition to bleed, especially wh...
Detailed Description
Kidney biopsy frequently is used to investigate the cause of suspected renal parenchymal disease. Although kidney biopsy may provide important diagnostic information and guide therapeutic decisions, t...
Eligibility Criteria
Inclusion
- all patients undergoing standard percutaneous renal biopsy performed in our Unit
Exclusion
- contraindication to standard percutaneous renal biopsy
Key Trial Info
Start Date :
June 13 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2019
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT03762707
Start Date
June 13 2019
End Date
September 1 2019
Last Update
June 18 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AOUConsorziale Policlinico Di Bari
Bari, Italy, 70124